JOHN PATIENCE - Corporate Board Profile

Accelerate Diagnostics, Inc

Filing Date	Source Excerpt
2012-05-17	Mr. Patience, 64, is also a founding partner of Crabtree Partners, a private equity investment firm. Mr. Patience served as a director of Ventana Medical Systems, Inc. from 1989 and as Vice Chairman from 1999 until Ventana’s acquisition by Roche in 2008. Mr. Patience has been a director of Stericycle, Inc. (NASDAQ: SRCL) since 1989. Mr. Patience was previously a partner of a venture capital investment firm that provided both Ventana and Stericycle with early stage funding. Mr. Patience was also previously a partner in the consulting firm of McKinsey & Company, Inc., specializing in health care. Mr. Patience holds a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an M.B.A. from the University of Pennsylvania’s Wharton School of Business.
2012-11-13	John Patience has served as a Director of the Company since June 26, 2012. ... Mr. Patience is the Chairman of the Board. ... Jack Schuler and Matthew W. Strobeck, Ph.D., each independent directors, serve as members of our Audit Committee. ... The table below sets forth the compensation of our directors for serving as our directors for the fiscal year ended July 31, 2012: ... John Patience fees earned or paid in cash: —, non-equity stock awards: —, option awards: —, total: —.
2013-11-05	John Patience has served as a Director of the Company since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm.
2014-04-15	John Patience 65 Chairman of the Board of Directors John Patience 212,542 Includes annual award of option to purchase 44,670 shares of common stock at an exercise price of $6.48 per share, which vests in 12 equal monthly installments with the first installment vesting on May 3, 2013.
2015-04-08	John Patience has served as a Director of the Company since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm. Mr. Patience served as a director of Ventana Medical Systems, Inc. from 1989 and as Vice Chairman from 1999 until Ventana’s acquisition by Roche in 2008. Mr. Patience has been a director of Stericycle, Inc. (NASDAQ: SRCL) since 1989. Mr. Patience was previously a partner of a venture capital investment firm that provided both Ventana and Stericycle with early stage funding. Mr. Patience was also previously a partner in the consulting firm of McKinsey & Co., Inc., specializing in health care. Mr. Patience holds a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an M.B.A. from the University of Pennsylvania’s Wharton School of Business.
2016-04-01	John Patience 67 Chairman of the Board of Directors John Patience has served as a Director of the Company since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm. The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink.
2017-04-10	John Patience 68 Chairman of the Board of Directors ...The Board maintains a standing Compensation Committee comprised of Messrs. Miller, Patience, Schuler, Strobeck and ten Brink...The Compensation Committee met 3 times during the year ended December 31, 2016. ...The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2016: John Patience 79,519 79,519
2018-04-12	The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2017: John Patience Option Award(1) ($) 161,802 Total ($) 161,802
2019-04-05	John Patience has served as a Director of the Company since June 26, 2012. Currently, John Patience serves as the Chairman of the Board. The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2018: John Patience (6) 115,667(2) 115,667 As of December 31, 2018, Mr. Patience held 51,464 options to purchase shares of our common stock.
2020-04-01	John Patience has served as a Director of the Company since June 26, 2012. ... The Board maintains a standing Compensation Committee comprised of Messrs. Brown (Chairman) and Patience, Ms. Francesconi and Dr. Watts. ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2019: John Patience (9) Option Award (1) ($) 133,904 Total ($) 133,904
2021-04-05	John Patience 73 Chairman of the Board of Directors... The Board has affirmatively determined that directors... Patience... are independent directors... The Board maintains a standing Compensation Committee comprised of Messrs. Brown (Chairman) and Patience, Ms. Francesconi and Dr. Watts... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2020: John Patience 58,254 58,254
2022-04-07	John Patience has served as a Director of the Company and board chairman since June 26, 2012. ... The Board has affirmatively determined that directors ... Patience ... are “independent directors” ... The following table provides current membership for each committee of our board of directors: John Patience Audit Committee ... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2021: John Patience 140,799
2023-05-01	John Patience has served as a Director of the Company since June 26, 2012... The following table sets forth the compensation of our directors for serving as our directors for the year ended December 31, 2022: John Patience 45,569
2024-04-11	Mr. Patience earned a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an MBA from the University of Pennsylvania’s Wharton School of Business.